This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saleh, M. Articles by Wilks, A. F. Search for Related Content PubMed PubMed Citation Articles by Saleh, M. Articles by Wilks, A. F.

Inhibition of Growth of C6 Glioma Cells in Vivo by Expression of Antisense Vascular Endothelial Growth Factor Sequence¹

Neuroscience Center, Department of Surgery, The University of Melbourne, Grattan Street [M. S.], and Growth Regulation Laboratory, Ludwig Institute for Cancer Research, Melbourne Tumor Biology Branch, P.O. Box 2008 [S. A. S., A. F. W.], Parkville Victoria 3050, Australia

Tumor angiogenesis involves a combination of events including the production of inhibitors, proteases, and angiogenic factors that have a chemotactic and mitogenic effect on endothelial cells. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that promotes angiogenesis in solid tumors, including brain tumors such as astrocytomas. As an approach to the development of new strategies for gene therapy of brain tumors, we have interrupted the VEGF/VEGF receptor paracrine pathway in an attempt to inhibit angiogenesis and thereby control tumor growth. Rat C6 glioma cells were transfected with a eukaryotic expression vector bearing an antisense-VEGF cDNA. Stable transfectants were observed to express reduced levels of VEGF in culture under hypoxic conditions. When implanted s.c. into nude (nu/nu) mice, growth of the antisense-VEGF cell lines was observed to be greatly inhibited compared to control cells, despite the fact that they have a faster division time in vitro. Analysis of these tumors revealed that they have fewer blood vessels and a higher degree of necrosis, which is a plausible explanation for the reduced tumor size. We believe antisense-VEGF can be successfully used to control tumor growth and may provide the basis for the development of antiangiogenic gene therapy.

¹ M. S. was supported by a National Health and Medical Research Council Australian Postdoctoral Fellowship. S. A. S. and A. F. W. acknowledge the support of the National Health and Medical Research Council.

² To whom requests for reprints should be addressed. Phone: 61-3-9342-7616; Fax: 61-3-9347-8332.

Received 8/15/95. Accepted 11/13/95.

This article has been cited by other articles:

				S. V. Sharma and J. Settleman Oncogene addiction: setting the stage for molecularly targeted cancer therapy Genes & Dev., December 15, 2007; 21(24): 3214 - 3231. [Abstract] [Full Text] [PDF]

				F. Tian, C.-h. Zhu, X.-w. Zhang, X. Xie, X.-l. Xin, Y.-h. Yi, L.-p. Lin, M.-y. Geng, and J. Ding Philinopside E, a New Sulfated Saponin from Sea Cucumber, Blocks the Interaction between Kinase Insert Domain-Containing Receptor (KDR) and {alpha}vbeta3 Integrin via Binding to the Extracellular Domain of KDR Mol. Pharmacol., September 1, 2007; 72(3): 545 - 552. [Abstract] [Full Text] [PDF]

				M. Reinblatt, R. H. Pin, W. J. Bowers, H. J. Federoff, and Y. Fong Herpes Simplex Virus Amplicon Delivery of a Hypoxia-Inducible Soluble Vascular Endothelial Growth Factor Receptor (sFlk-1) Inhibits Angiogenesis and Tumor Growth in Pancreatic Adenocarcinoma Ann. Surg. Oncol., December 1, 2005; 12(12): 1025 - 1036. [Abstract] [Full Text] [PDF]

				C. Cristina, G. Diaz-Torga, A. Baldi, A. Gongora, M. Rubinstein, M. J. Low, and D. Becu-Villalobos Increased Pituitary Vascular Endothelial Growth Factor-A in Dopaminergic D2 Receptor Knockout Female Mice Endocrinology, July 1, 2005; 146(7): 2952 - 2962. [Abstract] [Full Text] [PDF]

				K. Schmidt, J. Hoffend, A. Altmann, L. G. Strauss, A. Dimitrakopoulou-Strauss, B. Engelhardt, D. Koczan, J. Peter, S. Vorwald, H. Eskerski, et al. Transfer of the sFLT-1 Gene in Morris Hepatoma Results in Decreased Growth and Perfusion and Induction of Genes Associated with Stress Response Clin. Cancer Res., March 15, 2005; 11(6): 2132 - 2140. [Abstract] [Full Text] [PDF]

				I. Serganova, M. Doubrovin, J. Vider, V. Ponomarev, S. Soghomonyan, T. Beresten, L. Ageyeva, A. Serganov, S. Cai, J. Balatoni, et al. Molecular Imaging of Temporal Dynamics and Spatial Heterogeneity of Hypoxia-Inducible Factor-1 Signal Transduction Activity in Tumors in Living Mice Cancer Res., September 1, 2004; 64(17): 6101 - 6108. [Abstract] [Full Text] [PDF]

				N. Ferrara Vascular Endothelial Growth Factor: Basic Science and Clinical Progress Endocr. Rev., August 1, 2004; 25(4): 581 - 611. [Abstract] [Full Text] [PDF]

				A. L. Rakhmilevich, A. T. Hooper, D. J. Hicklin, and P. M. Sondel Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody Mol. Cancer Ther., August 1, 2004; 3(8): 969 - 976. [Abstract] [Full Text] [PDF]

				A. Sako, J. Kitayama, H. Koyama, H. Ueno, H. Uchida, H. Hamada, and H. Nagawa Transduction of Soluble Flt-1 Gene to Peritoneal Mesothelial Cells Can Effectively Suppress Peritoneal Metastasis of Gastric Cancer Cancer Res., May 15, 2004; 64(10): 3624 - 3628. [Abstract] [Full Text] [PDF]

				S.-H. Tseng, S.-M. Lin, J.-C. Chen, Y.-H. Su, H.-Y. Huang, C.-K. Chen, P.-Y. Lin, and Y. Chen Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats Clin. Cancer Res., March 15, 2004; 10(6): 2190 - 2202. [Abstract] [Full Text] [PDF]

				P. N. Lara Jr., D. I. Quinn, K. Margolin, F. J. Meyers, J. Longmate, P. Frankel, P. C. Mack, C. Turrell, P. Valk, J. Rao, et al. SU5416 Plus Interferon {alpha} in Advanced Renal Cell Carcinoma: A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition Clin. Cancer Res., October 15, 2003; 9(13): 4772 - 4781. [Abstract] [Full Text] [PDF]

				R. Giavazzi, B. Sennino, D. Coltrini, A. Garofalo, R. Dossi, R. Ronca, M. P. M. Tosatti, and M. Presta Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tumor Growth and Angiogenesis Am. J. Pathol., June 1, 2003; 162(6): 1913 - 1926. [Abstract] [Full Text] [PDF]

				E. Barbera-Guillem, J. K. Nyhus, C. C. Wolford, C. R. Friece, and J. W. Sampsel Vascular Endothelial Growth Factor Secretion by Tumor-infiltrating Macrophages Essentially Supports Tumor Angiogenesis, and IgG Immune Complexes Potentiate the Process Cancer Res., December 1, 2002; 62(23): 7042 - 7049. [Abstract] [Full Text] [PDF]

				N. Gao, B.-H. Jiang, S. S. Leonard, L. Corum, Z. Zhang, J. R. Roberts, J. Antonini, J. Z. Zheng, D. C. Flynn, V. Castranova, et al. p38 Signaling-mediated Hypoxia-inducible Factor 1alpha and Vascular Endothelial Growth Factor Induction by Cr(VI) in DU145 Human Prostate Carcinoma Cells J. Biol. Chem., November 15, 2002; 277(47): 45041 - 45048. [Abstract] [Full Text] [PDF]

				Y. Liang, X.-Y. Li, E. J. Rebar, P. Li, Y. Zhou, B. Chen, A. P. Wolffe, and C. C. Case Activation of Vascular Endothelial Growth Factor A Transcription in Tumorigenic Glioblastoma Cell Lines by an Enhancer with Cell Type-specific DNase I Accessibility J. Biol. Chem., May 24, 2002; 277(22): 20087 - 20094. [Abstract] [Full Text] [PDF]

				M. Colleoni, A. Rocca, M. T. Sandri, L. Zorzino, G. Masci, F. Nole, G. Peruzzotti, C. Robertson, L. Orlando, S. Cinieri, et al. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels Ann. Onc., January 19, 2002; 13(1): 73 - 80. [Abstract] [Full Text] [PDF]

				M. Sato, T. Tanaka, T. Maeno, Y. Sando, T. Suga, Y. Maeno, H. Sato, R. Nagai, and M. Kurabayashi Inducible Expression of Endothelial PAS Domain Protein-1 by Hypoxia in Human Lung Adenocarcinoma A549 Cells . Role of Src Family Kinases-dependent Pathway Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 127 - 134. [Abstract] [Full Text] [PDF]

				M. E. Baldwin, S. Roufail, M. M. Halford, K. Alitalo, S. A. Stacker, and M. G. Achen Multiple Forms of Mouse Vascular Endothelial Growth Factor-D Are Generated by RNA Splicing and Proteolysis J. Biol. Chem., November 16, 2001; 276(47): 44307 - 44314. [Abstract] [Full Text] [PDF]

				P. Kunkel, U. Ulbricht, P. Bohlen, M. A. Brockmann, R. Fillbrandt, D. Stavrou, M. Westphal, and K. Lamszus Inhibition of Glioma Angiogenesis and Growth in Vivo by Systemic Treatment with a Monoclonal Antibody against Vascular Endothelial Growth Factor Receptor-2 Cancer Res., September 1, 2001; 61(18): 6624 - 6628. [Abstract] [Full Text] [PDF]

				P. J. Mahasreshti, J. G. Navarro, M. Kataram, M. H. Wang, D. Carey, G. P. Siegal, M. N. Barnes, D. M. Nettelbeck, R. D. Alvarez, A. Hemminki, et al. Adenovirus-mediated Soluble FLT-1 Gene Therapy for Ovarian Carcinoma Clin. Cancer Res., July 1, 2001; 7(7): 2057 - 2066. [Abstract] [Full Text] [PDF]

				Q. Shi, X. Le, J. L. Abbruzzese, Z. Peng, C.-N. Qian, H. Tang, Q. Xiong, B. Wang, X.-C. Li, and K. Xie Constitutive Sp1 Activity Is Essential for Differential Constitutive Expression of Vascular Endothelial Growth Factor in Human Pancreatic Adenocarcinoma Cancer Res., May 1, 2001; 61(10): 4143 - 4154. [Abstract] [Full Text]

				K. Ozawa, Y. Tsukamoto, O. Hori, Y. Kitao, H. Yanagi, D. M. Stern, and S. Ogawa Regulation of Tumor Angiogenesis by Oxygen-regulated Protein 150, an Inducible Endoplasmic Reticulum Chaperone Cancer Res., May 1, 2001; 61(10): 4206 - 4213. [Abstract] [Full Text]

				A. Jones, C. Fujiyama, C. Blanche, J. W. Moore, S. Fuggle, D. Cranston, R. Bicknell, and Adrian. L. Harris Relation of Vascular Endothelial Growth Factor Production to Expression and Regulation of Hypoxia-inducible Factor-1{{alpha}} and Hypoxia-inducible Factor-2{{alpha}} in Human Bladder Tumors and Cell Lines Clin. Cancer Res., May 1, 2001; 7(5): 1263 - 1272. [Abstract] [Full Text]

				P. Y.P. Lam and X. O. Breakefield Potential of gene therapy for brain tumors Hum. Mol. Genet., April 1, 2001; 10(7): 777 - 787. [Abstract] [Full Text] [PDF]

				R. Giavazzi, R. Giuliani, D. Coltrini, M. R. Bani, C. Ferri, B. Sennino, M. P. M. Tosatti, A. Stoppacciaro, and M. Presta Modulation of Tumor Angiogenesis by Conditional Expression of Fibroblast Growth Factor-2 Affects Early but not Established Tumors Cancer Res., January 1, 2001; 61(1): 309 - 317. [Abstract] [Full Text]

				N. W. Bengtson and D. I. H. Linzer Inhibition of Tumor Growth by the Antiangiogenic Placental Hormone, Proliferin-Related Protein Mol. Endocrinol., December 1, 2000; 14(12): 1934 - 1943. [Abstract] [Full Text]

				D. B. Mendel, R. E. Schreck, D. C. West, G. Li, L. M. Strawn, S. S. Tanciongco, S. Vasile, L. K. Shawver, and J. M. Cherrington The Angiogenesis Inhibitor SU5416 Has Long-lasting Effects on Vascular Endothelial Growth Factor Receptor Phosphorylation and Function Clin. Cancer Res., December 1, 2000; 6(12): 4848 - 4858. [Abstract] [Full Text]

				A. Maity, N. Pore, J. Lee, D. Solomon, and D. M. O’Rourke Epidermal Growth Factor Receptor Transcriptionally Up-Regulates Vascular Endothelial Growth Factor Expression in Human Glioblastoma Cells via a Pathway Involving Phosphatidylinositol 3'-Kinase and Distinct from That Induced by Hypoxia Cancer Res., October 1, 2000; 60(20): 5879 - 5886. [Abstract] [Full Text]

				F. Ciardiello, R. Bianco, V. Damiano, G. Fontanini, R. Caputo, G. Pomatico, Sabino De Placido, A. R. Bianco, J. Mendelsohn, and G. Tortora Antiangiogenic and Antitumor Activity of Anti-Epidermal Growth Factor Receptor C225 Monoclonal Antibody in Combination with Vascular Endothelial Growth Factor Antisense Oligonucleotide in Human GEO Colon Cancer Cells Clin. Cancer Res., September 1, 2000; 6(9): 3739 - 3747. [Abstract] [Full Text]

				K. Spilsbury, K. L. Garrett, W.-Y. Shen, I. J. Constable, and P. E. Rakoczy Overexpression of Vascular Endothelial Growth Factor (VEGF) in the Retinal Pigment Epithelium Leads to the Development of Choroidal Neovascularization Am. J. Pathol., July 1, 2000; 157(1): 135 - 144. [Abstract] [Full Text] [PDF]

				K. Inoue, J. W. Slaton, D. W. Davis, D. J. Hicklin, D. J. McConkey, T. Karashima, R. Radinsky, and C. P. N. Dinney Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel Clin. Cancer Res., July 1, 2000; 6(7): 2635 - 2643. [Abstract] [Full Text]

				H. Kuniyasu, P. Troncoso, D. Johnston, C. D. Bucana, E. Tahara, I. J. Fidler, and C. A. Pettaway Relative Expression of Type IV Collagenase, E-cadherin, and Vascular Endothelial Growth Factor/Vascular Permeability Factor in Prostatectomy Specimens Distinguishes Organ-confined from Pathologically Advanced Prostate Cancers Clin. Cancer Res., June 1, 2000; 6(6): 2295 - 2308. [Abstract] [Full Text]

				H. M. Fathallah-Shaykh, A. I. Kafrouni, L.-J. Zhao, G. M. Smith, and J. Forman Gene Transfer into Brain Parenchyma Elicits Antitumor Effects Cancer Res., April 1, 2000; 60(7): 1797 - 1799. [Abstract] [Full Text]

				K. Takayama, H. Ueno, Y. Nakanishi, T. Sakamoto, K. Inoue, K. Shimizu, H. Oohashi, and N. Hara Suppression of Tumor Angiogenesis and Growth by Gene Transfer of a Soluble Form of Vascular Endothelial Growth Factor Receptor into a Remote Organ Cancer Res., April 1, 2000; 60(8): 2169 - 2177. [Abstract] [Full Text]

				H.M. Pinedo and D. J. Slamon INTRODUCTION: Translational Research: The Role of VEGF in Tumor Angiogenesis Oncologist, April 1, 2000; 5(90001): 1 - 2. [Full Text]

				X.-W. Liu, Y. Katagiri, H. Jiang, L.-J. Gong, L.-Y. Guo, M. Shibutani, A. C. Johnson, and G. Guroff Cloning and Characterization of the Promoter Region of the Rat Epidermal Growth Factor Receptor Gene and Its Transcriptional Regulation by Nerve Growth Factor in PC12 Cells J. Biol. Chem., March 15, 2000; 275(10): 7280 - 7288. [Abstract] [Full Text] [PDF]

				L. Angelov, B. Salhia, L. Roncari, G. McMahon, and A. Guha Inhibition of Angiogenesis by Blocking Activation of the Vascular Endothelial Growth Factor Receptor 2 Leads to Decreased Growth of Neurogenic Sarcomas Cancer Res., November 1, 1999; 59(21): 5536 - 5541. [Abstract] [Full Text] [PDF]

				S. S. Chang, D. S. O'Keefe, D. J. Bacich, V. E. Reuter, W. D. W. Heston, and P. B. Gaudin Prostate-specific Membrane Antigen Is Produced in Tumor-associated Neovasculature Clin. Cancer Res., October 1, 1999; 5(10): 2674 - 2681. [Abstract] [Full Text] [PDF]

				H. Yoshiji, S. Kuriyama, D. K. Ways, J. Yoshii, Y. Miyamoto, M. Kawata, Y. Ikenaka, H. Tsujinoue, T. Nakatani, M. Shibuya, et al. Protein Kinase C Lies on the Signaling Pathway for Vascular Endothelial Growth Factor-mediated Tumor Development and Angiogenesis Cancer Res., September 1, 1999; 59(17): 4413 - 4418. [Abstract] [Full Text] [PDF]

				C.E. Gargett, F.L. Lederman, T.M. Lau, N.H. Taylor, and P.A.W. Rogers Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium Hum. Reprod., August 1, 1999; 14(8): 2080 - 2088. [Abstract] [Full Text] [PDF]

				H. Fathallah-Shaykh New Molecular Strategies to Cure Brain Tumors Arch Neurol, April 1, 1999; 56(4): 449 - 453. [Abstract] [Full Text] [PDF]

				L. M. Wise, T. Veikkola, A. A. Mercer, L. J. Savory, S. B. Fleming, C. Caesar, A. Vitali, T. Makinen, K. Alitalo, and S. A. Stacker Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1 PNAS, March 16, 1999; 96(6): 3071 - 3076. [Abstract] [Full Text] [PDF]

				M. Saleh, A. Wiegmans, Q. Malone, S. S. Stylli, and A. H. Kaye Effect of In Situ Retroviral Interleukin-4 Transfer on Established Intracranial Tumors J Natl Cancer Inst, March 3, 1999; 91(5): 438 - 445. [Abstract] [Full Text] [PDF]

				S.-A. Im, C. Gomez-Manzano, J. Fueyo, T.-J. Liu, L. D. Ke, J.-S. Kim, H.-Y. Lee, P. A. Steck, A. P. Kyritsis, and W. K. A. Yung Antiangiogenesis Treatment for Gliomas: Transfer of Antisense-Vascular Endothelial Growth Factor Inhibits Tumor Growth in Vivo Cancer Res., February 1, 1999; 59(4): 895 - 900. [Abstract] [Full Text] [PDF]

				J.-P. Theurillat, J. Hainfellner, A. Maddalena, J. Weissenberger, and A. Aguzzi Early Induction of Angiogenetic Signals in Gliomas of GFAP-v-src Transgenic Mice Am. J. Pathol., February 1, 1999; 154(2): 581 - 590. [Abstract] [Full Text] [PDF]

				G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J, January 1, 1999; 13(1): 9 - 22. [Abstract] [Full Text]

				T. A. T. Fong, L. K. Shawver, L. Sun, C. Tang, H. App, T. J. Powell, Y. H. Kim, R. Schreck, X. Wang, W. Risau, et al. SU5416 Is a Potent and Selective Inhibitor of the Vascular Endothelial Growth Factor Receptor (Flk-1/KDR) That Inhibits Tyrosine Kinase Catalysis, Tumor Vascularization, and Growth of Multiple Tumor Types Cancer Res., January 1, 1999; 59(1): 99 - 106. [Abstract] [Full Text] [PDF]

				A. Stratmann, W. Risau, and K. H. Plate Cell Type-Specific Expression of Angiopoietin-1 and Angiopoietin-2 Suggests a Role in Glioblastoma Angiogenesis Am. J. Pathol., November 1, 1998; 153(5): 1459 - 1466. [Abstract] [Full Text] [PDF]

				J. Folkman Antiangiogenic gene therapy PNAS, August 4, 1998; 95(16): 9064 - 9066. [Full Text] [PDF]

				F. Okada, J. W. Rak, B. St. Croix, B. Lieubeau, M. Kaya, L. Roncari, S. Shirasawa, T. Sasazuki, and R. S. Kerbel Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells PNAS, March 31, 1998; 95(7): 3609 - 3614. [Abstract] [Full Text] [PDF]

				S.-Y. Cheng, M. Nagane, H.-J. S. Huang, and W. K. Cavenee Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189 PNAS, October 28, 1997; 94(22): 12081 - 12087. [Abstract] [Full Text] [PDF]

				I. Desbaillets, A.-C. Diserens, N. d. Tribolet, M.-F. Hamou, and E. G.  V. Meir Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis J. Exp. Med., October 20, 1997; 186(8): 1201 - 1212. [Abstract] [Full Text] [PDF]

				D. S. Winlaw Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases Ann. Thorac. Surg., October 1, 1997; 64(4): 1204 - 1211. [Abstract] [Full Text]

				R. O SCHLINGEMANN and V. W M VAN HINSBERGH Role of vascular permeability factor/vascular endothelial growth factor in eye disease Br. J. Ophthalmol., June 1, 1997; 81(6): 501 - 512. [Full Text] [PDF]

				M. S. Pepper Manipulating Angiogenesis: From Basic Science to the Bedside Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 605 - 619. [Abstract] [Full Text]

				M. E. Baldwin, B. Catimel, E. C. Nice, S. Roufail, N. E. Hall, K. L. Stenvers, M. J. Karkkainen, K. Alitalo, S. A. Stacker, and M. G. Achen The Specificity of Receptor Binding by Vascular Endothelial Growth Factor-D Is Different in Mouse and Man J. Biol. Chem., May 25, 2001; 276(22): 19166 - 19171. [Abstract] [Full Text] [PDF]